Green Dot appoints Starboard Value's Peter Feld to board of directors

GREEN DOT CORP

Peter Feld appointed to the board effective March 11, 2022; he is Managing Member and Head of Research at Starboard Value LP.
Feld will receive pro rata portion of $70,000 annual retainer and eligible for $125,000 RSU grant at next annual meeting.
Starboard Value is one of Green Dot's largest long-term shareholders; Feld cites belief company is deeply undervalued.
Feld currently chairs GCP Applied Technologies and serves on NortonLifeLock board; has prior board roles at multiple public companies.
Appointment reflects ongoing relationship with activist investor; no arrangements or transactions under Item 404(a).

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Peter Feld

member of the board of directors

GDOT · GREEN DOT CORP

Effective: 2022-03-11
Filed: March 15, 2022, 7:59 PM ET

On March 14, 2022, Green Dot Corporation (the “Company”) announced the appointment of Peter Feld, age 43, as a member of the board of directors of the Company (the “Board”), effective March 11, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter Feld was appointed as member of the board of directors at GREEN DOT CORP.

Action: appointed
Role: member of the board of directors

Exact text from the filing

On March 14, 2022, Green Dot Corporation (the “Company”) announced the appointment of Peter Feld, age 43, as a member of the board of directors of the Company (the “Board”), effective March 11, 2022.

View on SEC.gov

GREEN DOT CORP filing history →

Source: SEC EDGAR

accession 0001386278-22-000010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.